leisure time -WSS

leisure time

author：leisure time 2025-09-30 22:04:19 - browse：2

NIH headquarters — NIH research fellows want to unionize, in large part because they want a raise. Will that mean less money for grants? Lydia Polimeni/NIH

Several thousand research fellows at the National Institutes of Health want to unionize, in large part because they want to raise their pay stipends to something resembling a living wage near the agency headquarters in Bethesda, Md. But with a Congress that is looking on in suspicion at the NIH’s research and a debt ceiling deal that limits budget increases, where is the money going to come from?

Unlike private companies, federal agencies can’t always just give raises. This varies widely across the government, and from position to position. NIH trainees actually have it better than most, because they aren’t subject to the rigid federal pay scale that governs how much most people working in the administration can make. That doesn’t mean, however, that there’s always money for raises. It’s Congress, not the NIH itself, that sets the agency’s budget.

Finding money for raises, therefore, necessarily means taking money from somewhere else, said Richard Freeman, a professor of economics at Harvard.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Readers respond to H5N1 and livestock movements, and more

WSS

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Venture capitalist Bob Kocher on the state of digital health

Case highlights the risks of experimental stem cell therapy

Roche subsidiary Foundation Medicine opens new headquarters

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Criminal prosecution for violating HIPAA: an emerging threat

leisure time

leisure time

Wikipedia

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Abortion pill case raises question: who can sue the FDA?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Supreme Court mifepristone arguments center on docs' right to sue

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Covid vaccine financial winners and losers, from Pfizer to Novavax

Peter Hotez and the public health issue of online harassment

Scientists boost immune system in aging mice by making it youthful

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Patient advocates debate FDA's accelerated approval process

explore

Readout Newsletter: Merck, Vertex, and Viking updates

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Study says nonprofit hospitals fall short in charity care spending

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Arc Institute generative AI designs new CRISPR systems

FDA's naming rule on biosimilars has undermined competition

hotspot

leisure time

entertainment

Wikipedia